Management of MF
Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts

Released: April 11, 2020

Activity

Progress
1
Course Completed

In this episode, John Mascarenhas, MD, and Ruben A. Mesa, MD, FACP, discuss current best practices and emerging approaches for treating patients with myelofibrosis, including:

  • Overall approach to treatment
  • Use of JAK inhibitors for treating myelofibrosis
  • Treating patients with low platelets
  • Defining JAK inhibitor failure
  • Unmet needs in treatment and emerging therapeutic options, including momelotinib, luspatercept, ruxolitinib add-on therapy, and other phase III approaches